Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-05-27 @ 12:55 PM
Study NCT ID:
NCT01297504
Status:
COMPLETED
Last Update Posted:
2014-10-01
First Post:
2011-02-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Respiratory Syncytial Virus Infection | View |